Advances in Treatment for Infectious Diseases
16th Lorne Infection and Immunity 2026
Days
Wednesday, 18th February
Thursday, 19th February
Friday, 20th February
Tracks
Adaptive Immunity
Advances in Treatment for Infectious Diseases
Emerging Infectious Disease Threats (and/or Antimicrobial Resistance)
Host-Pathogen Interactions
Innate Immunity
Microbiota and Mucosal Infections
Molecular Basis of Infectious Diseases
Search
Speakers
Session 12: Advances in Treatment for Infectious Disease
11:15AM - 1:00PM
Friday, 20th February
Heritage Ballroom
Chair: Stuart Ralph
Targeting Protective B Cell Epitopes for Prophylactic and Therapeutic Antibodies against Mpox
-
Camila Coelho
Orthology- and mutational constraint-guided drug repurposing efficiently identifies narrow-spectrum inhibitor of
Mycobacterium tuberculosis
acting through a new target
-
Eachan O Johnson
Unfolding malaria parasite biology by targeting protein disulphide isomerases to block
Plasmodium
invasion and transmission
-
Senna Steen
New functions for γδ T cell-derived IL-4 in immunity to liver stage malaria
-
Lynette Beattie
Using in vivo models to understand and target the drivers of inflammation and disease during severe acute SARS-CoV-2 infection and long COVID
-
Marcel Doerflinger